Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy

Bedke, Jens; Gouttefangeas, Cecile; Singh-Jasuja, Harpreet; Stevanovic, Stefan; Behnes, Carl-Ludwig; Stenzl, Arnulf

dc.contributor.author	Bedke, Jens
dc.contributor.author	Stenzl, Arnulf
dc.contributor.author	Gouttefangeas, Cécile
dc.contributor.author	Stevanović, Stefan
dc.date.accessioned	2014-07-30T15:21:21Z
dc.date.available	2014-07-30T15:21:21Z
dc.date.issued	2014
dc.identifier.issn	0724-4983
dc.identifier.uri	http://hdl.handle.net/10900/55034
dc.language.iso	en	en
dc.publisher	Springer	de_DE
dc.relation.uri	http://dx.doi.org/10.1007/s00345-013-1033-3	de_DE
dc.rights	info:eu-repo/semantics/closedAccess
dc.subject.ddc	610	de_DE
dc.title	Targeted therapy in renal cell carcinoma: moving from molecular agents to specific immunotherapy	de_DE
dc.type	Article	de_DE
utue.quellen.id	20140610213910_00893	de_DE
utue.publikation.seiten	31-38	de_DE
utue.personen.roh	Bedke, Jens
utue.personen.roh	Gouttefangeas, Cecile
utue.personen.roh	Singh-Jasuja, Harpreet
utue.personen.roh	Stevanovic, Stefan
utue.personen.roh	Behnes, Carl-Ludwig
utue.personen.roh	Stenzl, Arnulf
dcterms.isPartOf.ZSTitelID	World Journal of Urology	de_DE
dcterms.isPartOf.ZS-Issue	1	de_DE
dcterms.isPartOf.ZS-Volume	32	de_DE
utue.fakultaet	04 Medizinische Fakultät	de_DE